Read the docs
TI-2017-12938 Aliases CVE-2017-17677GHSA-vcfr-6pgp-8283

BMC Remedy 9.1SP3 is affected by authenticated code execution.

Priority MEDIUM 40CWE-732Published · Updated

Key facts

Attack vector
Network
Privileges required
Low
User interaction
None
Attack complexity
Low
Impact type
—
Confidentiality · integrity · availability
High · High · High
Fix status
No fix listed

Attack profile from CVSS 3.1 · NVD. Fix status from CNA.

Summary

BMC Remedy 9.1SP3 is affected by authenticated code execution. Authenticated users that have the right to create reports can use BIRT templates to run code.

Why it matters now

EPSS 0.0106 64th percentileScored 2026-11-07
Fix No fix listed No fixed version in the sources yet

SSVC decision points

Not available: CISA has not published SSVC decision points for this record.

Affected products

VendorProductAffected versionsFixed inStatusSource
——all versions—No fix listedCNA
  • — Vendor— Affected all versions Fixed in — No fix listed CNA

CPE configurations NVD · 1

CPEVersionsRoleVendor
cpe:2.3:a:bmc:remedy_mid-tier:9.1:sp3:*:*:*:*:*:*9.1 sp3VulnerableBMC
  • cpe:2.3:a:bmc:remedy_mid-tier:9.1:sp3:*:*:*:*:*:* Versions 9.1 sp3 Vulnerable ·BMC

Remediation

No fixed version listed by the sources yet.

Timeline

  1. 2026-10-02 Threatist record created from CVE-2017-17677
  2. 2026-10-03 Alias added: GHSA-vcfr-6pgp-8283

References

  • TI-2024-22737 **UNSUPPORTED WHEN ASSIGNED** An issue was discovered in BMC Remedy Mid Tier 7.6.04. CVSS 3.1CRITICAL 9.8
  • TI-2017-12936 BMC Remedy Mid Tier 9.1SP3 is affected by remote and local file inclusion. CVSS 3.1CRITICAL 9.8
  • TI-2018-13363 BMC Remedy Mid-Tier 7.1.00 and 9.1.02.003 for BMC Remedy AR System has Incorrect Access… CVSS 3.0HIGH 8.8
  • TI-2017-12939 BMC Remedy Mid Tier 9.1SP3 is affected by cross-site scripting (XSS). CVSS 3.1MEDIUM 6.1
  • TI-2017-12937 BMC Remedy Mid Tier 9.1SP3 is affected by log hijacking. CVSS 3.1MEDIUM 5.3
  • TI-2024-22736 An issue was discovered in BMC Remedy Mid Tier 7.6.04. CVSS 3.1MEDIUM 4.2

Sources